Drug combination provides a one-two punch attack against colorectal cancer
by National Cancer InstituteOn the left,SN38, the active metabolite of irinotecan, traps TOP1 on DNA, forming TOP1 cleavage complexes that are degraded upon their formation, as seen by the
Updated on: January 29,2024
10
Drug combination provides a one-two punch attack against colorectal cancer
by National Cancer InstituteOn the left,SN38, the active metabolite of irinotecan, traps TOP1 on DNA, forming TOP1 cleavage complexes that are degraded upon their formation, as seen by the
Updated on:January 29,2024
10
